MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cell death"

  • 2025 International Congress

    Investigating the cellular consequences of the G2385R LRRK2 variant

    P. Lewis, S. Herbst (London, United Kingdom)

    Objective: The objective of this study is to characterise the biochemical and cellular impact of the G2385R coding variant in LRRK2, a risk variant for…
  • 2025 International Congress

    Natural compound Protects Dopaminergic Neurons by Targeting Oxidative Stress and Cell Death Pathways in Parkinson’s Disease

    S. Pandey, R. Singh (Lucknow, India)

    Objective: This study aims to evaluate the neuroprotective potential of a natural compound that protects dopaminergic neurons by targeting oxidative stress and cell death pathways…
  • 2025 International Congress

    The Role of Autophagy Lysosomal and Ubiquitin Proteasomal System in the Pathophysiology of Parkinson’s disease.

    B. Adebisi (Akure, Nigeria)

    Objective: The research how to better understand the molecular mechanism initiating the etiology of Parkinson's disease in order to appropriate the precise diagnosis and therapeutic…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 specific microRNAs may have an effect on neurodegeneration.

    R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: 1.Identification of microRNA in whole blood PBMCs of SCA2 patients .2.Target prediction and pathway analysis of  spinocerebellar ataxia type 2 identified miRNAs.  3.Validation of…
  • 2024 International Congress

    the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms

    N. Palomba, E. Bianchini, D. Rinaldi, C. Strafella, V. Caputo, F. Garramone, P. Lombardo, F. Nicoletti, E. Giardina, T. Esposito, F. Pontieri, M. Alborghetti ()

    Objective: To study a possible association between polymorphisms of the genes coding for proteins involved in the UPR and the development of PD or PD…
  • 2024 International Congress

    the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.

    M. Alborghetti, E. Bianchini, D. Rinaldi, I. de Bartolo, L. Di Menna, G. Battaglia, V. Bruno, T. Esposito, M. Borro, M. Simmaco, F. Pontieri, A. Berardelli, F. Nicoletti (Rome, Italy)

    Objective: The aim of the study was to examine the association between polymorphic variants of GRM3 and GRM5 and Parkinson’s disease (PD) and motor and…
  • 2023 International Congress

    The incidence of Parkinson’s disease in Nigeria: a systematic review and meta-analysis

    A. Memudu, E. Ekhoye (Iyamho, Nigeria)

    Objective: The study aim to integrate various investigations pertaining to the incidence of Parkinson's disease (PD) in Nigeria, with the objective of comprehensively characterizing the…
  • 2023 International Congress

    Preliminary evidence for evolution of myoinositol and N-acteylaspartate as biomarkers of disease severity in early-stage multiple system atrophy

    P. Trujillo, J. Iregui, K. Hett, A. Wynn, M. Donahue, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

    Objective: To quantify the longitudinal evolution of metabolic indicators of gliosis and neuronal integrity in patients with multiple system atrophy (MSA) over one year. Background:…
  • 2022 International Congress

    Mutant WDR45 leads to altered ferroptosis in β-propeller protein-associated neurodegeneration

    S H. Diaw, C. Ganos, S. Zittel, K. Plötze-Martin, L. Kulikovskaja, A. Westenberger, M. Vos, A. Rakovic, M. Dulovic-Mahlow, K. Lohmann (Lübeck, Germany)

    Objective: To functionally characterize WDR45-mediated BPAN (Beta-propeller protein-associated neurodegeneration). Background: BPAN patients usually present with global developmental delay and autistic features in early childhood and…
  • 2022 International Congress

    Clove mediated Rescue in Parkinson’s Disease involves modulation of p53 and Sestrin2 in SHSY5Y cell line model

    N. Rai, S. Dey (Udaipur, India)

    Objective: The study analyzed the neuroprotective effect of ethanolic extract of clove against Parkinson’s disease (PD) type toxicity in SHSY5Y cell line model and interrogation…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley